Decision cost hypersensitivity underlies Huntington's disease apathy.

Huntington’s disease apathy decision-making delay effort

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
12 Sep 2024
Historique:
received: 14 05 2024
accepted: 11 09 2024
medline: 13 9 2024
pubmed: 13 9 2024
entrez: 13 9 2024
Statut: aheadofprint

Résumé

The neuropsychiatric syndrome of apathy is now recognized to be a common and disabling condition in Huntington's disease (HD). However, the mechanisms underlying it are poorly understood. One way to investigate apathy is to utilise a theoretical framework of normal motivated behaviour, to determine where breakdown has occurred in people with this behavioural disruption. A fundamental computation underlying motivated, goal-directed behaviour across species is weighing up the costs and rewards associated with actions. Here, we asked whether people with apathy are more sensitive to costs of actions (physical effort and time delay), less sensitive to rewarding outcomes, or both. Based on the unique anatomical substrates associated with HD pathology, we hypothesised that a general hypersensitivity to costs would underpin HD apathy. Genetically confirmed carriers of the expanded Huntingtin gene (premanifest to mild motor manifest disease (n=53) were compared to healthy controls (n = 38). Participants performed a physical effort-based decision-making task (Apple Gathering Task) and a delay discounting task (Money Choice Questionnaire). Choice data was analysed using linear regression and drift diffusion models that also accounted for the time taken to make decisions. Apathetic people with HD accepted fewer offers overall on the Apple Gathering Task, specifically driven by increased sensitivity to physical effort costs, and not explained by motor severity, mood, cognition, or medication. Drift diffusion modelling provided further evidence of effort hypersensitivity, with apathy associated with a faster drift rate towards rejecting offers as a function of varying effort. Increased delay sensitivity was also associated with apathy, both when analysing raw choice and also drift rate, where there was moderate evidence of HD apathy drifting faster towards the immediately available (low cost) option. Furthermore, the effort and delay sensitivity parameters from these tasks were positively correlated. The results demonstrate a clear mechanism for apathy in HD, cost hypersensitivity, which manifests in both the effort and time costs associated with actions towards rewarding goals. This suggests that HD pathology may cause a domain-general disruption of cost processing, which is distinct to apathy occurrence in other brain disorders, and may require different therapeutic approaches.

Identifiants

pubmed: 39269457
pii: 7756369
doi: 10.1093/brain/awae296
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.

Auteurs

Lee-Anne Morris (LA)

Department of Medicine, University of Otago, Christchurch, 8011, New Zealand.
New Zealand Brain Research Institute, Christchurch, 8011, New Zealand.

Kyla-Louise Horne (KL)

Department of Medicine, University of Otago, Christchurch, 8011, New Zealand.
New Zealand Brain Research Institute, Christchurch, 8011, New Zealand.

Sanjay Manohar (S)

Department of Experimental Psychology, University of Oxford, Oxford, OX2 6GG, UK.
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.

Laura Paermentier (L)

New Zealand Brain Research Institute, Christchurch, 8011, New Zealand.

Christina Buchanan (C)

Department of Neurology, Auckland city hospital, Te Whatu Ora Health New Zealand, Auckland, 1023, New Zealand.
Centre for Brain Research Neurogenetics Research Clinic, University of Auckland, Auckland, 1023, New Zealand.

Michael MacAskill (M)

New Zealand Brain Research Institute, Christchurch, 8011, New Zealand.

Daniel Myall (D)

New Zealand Brain Research Institute, Christchurch, 8011, New Zealand.

Matthew Apps (M)

Centre for Human Brain Health, School of Psychology, University of Birmingham, Birmingham, B15 2SQ, UK.

Richard Roxburgh (R)

Department of Neurology, Auckland city hospital, Te Whatu Ora Health New Zealand, Auckland, 1023, New Zealand.
Centre for Brain Research Neurogenetics Research Clinic, University of Auckland, Auckland, 1023, New Zealand.

Tim Anderson (T)

Department of Medicine, University of Otago, Christchurch, 8011, New Zealand.
New Zealand Brain Research Institute, Christchurch, 8011, New Zealand.
Department of Neurology, Christchurch hospital, Te Whatu Ora Health New Zealand, Christchurch, 8011, New Zealand.

Masud Husain (M)

Department of Experimental Psychology, University of Oxford, Oxford, OX2 6GG, UK.
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.

Campbell Le Heron (C)

Department of Medicine, University of Otago, Christchurch, 8011, New Zealand.
New Zealand Brain Research Institute, Christchurch, 8011, New Zealand.
Department of Neurology, Christchurch hospital, Te Whatu Ora Health New Zealand, Christchurch, 8011, New Zealand.

Classifications MeSH